CRP and myeloid sarcoma: Finally, Pelascini E et al. [30] reported 20.6% MHMO using more strict criteria according to Wildman et al. excluding MO patients with more than 2 conditions of MS, HOMA-IR over 2.5, and systemic inflammation by CRP above 5 mg/dL.